{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:10:38Z","timestamp":1778551838208,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["440010\/2018-7"],"award-info":[{"award-number":["440010\/2018-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302670\/2017-3"],"award-info":[{"award-number":["302670\/2017-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["403006\/2016-3"],"award-info":[{"award-number":["403006\/2016-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijantimicag.2019.06.020","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T12:50:19Z","timestamp":1562158219000},"page":"301-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis"],"prefix":"10.1016","volume":"54","author":[{"given":"Noelly Queiroz","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson Philip Nonato","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u00fazia Castro Peres","family":"Em\u00eddio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marliete Carvalho","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Jos\u00e9 Cotta","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Henrique Fonseca","family":"Carmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique Ferreira","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Bernardo","family":"de Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele Gl\u00f3ria","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiane Alves","family":"Paix\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1108-5666","authenticated-orcid":false,"given":"Daniel Assis","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0001","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1038\/s41598-017-04588-7","article-title":"High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis","volume":"7","author":"Santos","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0002","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fgb.2014.10.003","article-title":"Cryptococcosis diagnosis and treatment: What do we know now","volume":"78","author":"Perfect","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0003","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: from environmental saprophyte to global pathogen","volume":"14","author":"May","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0004","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/jiy447","article-title":"Association between plasma antibody responses and risk for cryptococcus-associated immune reconstitution inflammatory syndrome","volume":"219","author":"Yoon","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/EC.00314-12","article-title":"A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis","volume":"12","author":"Butts","year":"2013","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0006","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijantimicag.2017.04.005","article-title":"Atorvastatin as a promising anticryptococcal agent","volume":"49","author":"Ribeiro","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0007","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/jac\/dkt449","article-title":"Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms","volume":"69","author":"Delattin","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0008","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003980","article-title":"PPAR\u03b3 agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria","volume":"10","author":"Serghides","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18122548","article-title":"Human skin permeation studies with PPAR\u03b3 agonist to improve its permeability and efficacy in Inflammatory Processes","volume":"18","author":"Silva-Abreu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0011","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1096\/fj.201700075R","article-title":"Peroxisome proliferator-activated receptor-\u03b3 agonists attenuate biofilm formation by Pseudomonas aeruginosa","volume":"31","author":"Bedi","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0012","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0013","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clml.2019.01.006","article-title":"Adding oral pioglitazone to standard induction chemotherapy of acute myeloid leukemia: a randomized clinical trial","volume":"4","author":"Ghadiany","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0014","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00432-018-2791-5","article-title":"Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial","volume":"145","author":"Cramer","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13229-018-0241-5","article-title":"A pilot dose finding study of pioglitazone in autistic children","volume":"9","author":"Capano","year":"2018","journal-title":"Mol Autism"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188596","article-title":"Effects of peroxisome proliferator activated receptors (PPAR)-\u03b3 and -\u03b1 agonists on cochlear protection from oxidative stress","volume":"12","author":"Sekulic-Jablanovic","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0017","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0018","series-title":"Clinical and Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of yeasts Approved standard M27-A3","year":"2008"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0019","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/jac\/dkt114","article-title":"The role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen Cryptococcus gattii","volume":"68","author":"Ferreira","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0020","article-title":"Bone marrow-derived macrophages (BMM): isolation and applications","author":"Weischenfeldt","year":"2008","journal-title":"CSH Protoc"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0021","article-title":"Prevention of amphotericin B nephrotoxicity through use of phytotherapeutic medication","volume":"49","author":"Schlottfeldt","year":"2015","journal-title":"Rev Esc Enferm USP"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0022","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mib.2017.10.018","article-title":"Modulating host immune responses to fight invasive fungal infections","volume":"40","author":"Scriven","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0023","first-page":"1","article-title":"Understanding pathogenesis and care challenges of immune reconstitution inflammatory syndrome in fungal infections","volume":"4","author":"Delli\u00e8re","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0024","first-page":"1","article-title":"Monocyte phenotype and IFN-\u03b3-inducible cytokine responses are associated with cryptococcal immune reconstitution inflammatory syndrome","volume":"3","author":"Meya","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mmcr.2018.12.008","article-title":"Immune reconstitution inflammatory syndrome associated with disseminated histoplasmosis and TNF-alpha inhibition","volume":"23","author":"Wright","year":"2019","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4064628","article-title":"Increasing the fungicidal action of amphotericin b by inhibiting the nitric oxide-dependent tolerance pathway","volume":"2017","author":"Vriens","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0027","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrd3074","article-title":"An insight into the antifungal pipeline: selected new molecules and beyond","volume":"9","author":"Ostrosky-Zeichner","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0028","doi-asserted-by":"crossref","first-page":"9128","DOI":"10.1002\/anie.201404761","article-title":"Advancing the drug discovery and development process","volume":"53","author":"Nicolaou","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0029","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12974-017-0957-8","article-title":"Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation","volume":"14","author":"Omeragic","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0030","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fphar.2018.01103","article-title":"Pioglitazone represents an effective therapeutic target in preventing oxidative\/inflammatory cochlear damage induced by noise exposure","volume":"9","author":"Paciello","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2012.05.014","article-title":"Cardioprotection from oxidative stress in the newborn heart by activation of PPAR\u03b3 is mediated by catalase","volume":"53","author":"Chen","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0032","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopha.2017.08.083","article-title":"Peroxisome proliferator-activated receptors as therapeutic targets for heart failure","volume":"95","author":"Abushouk","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijantimicag.2019.06.020_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.02183-16","article-title":"Trojan horse transit contributes to blood-brain barrier crossing of a eukaryotic pathogen","volume":"8","author":"Santiago-Tirado","year":"2017","journal-title":"MBio"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:27:49Z","timestamp":1778549269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919301736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0924857919301736"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.06.020","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}